z-logo
Premium
Localized synovial sarcoma: A single institutional study of 191 patients with a minimum follow‐up of 5 years for survivors
Author(s) -
Outani Hidetatsu,
Nakamura Tomoki,
Murata Hiroaki,
Stevenson Jonathan,
Parry Michael,
Gregory Jonathan,
Tillman Roger,
Jeys Lee,
Abudu Adesegun
Publication year - 2019
Publication title -
journal of surgical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.201
H-Index - 111
eISSN - 1096-9098
pISSN - 0022-4790
DOI - 10.1002/jso.25417
Subject(s) - medicine , multivariate analysis , synovial sarcoma , surgery , sarcoma , metastasis , localized disease , distant metastasis , cancer , soft tissue , pathology , prostate cancer
Purpose Factors affecting long‐term outcomes of synovial sarcoma (SS) remain unknown. Here, we aimed to investigate the long‐term oncological outcomes and prognostic factors in a large group of patients with surgically‐treated localized SS. Patients and Methods Between 1980 and 2011, 191 patients (94 males and 97 females) were treated at a single hospital with a minimum follow‐up of 5 years for survivors. The median age was 35 years (range, 3‐80 years), and the median follow‐up period was 83 months (range, 3‐235 months). Results Disease‐specific survival was 76.4% and 60.4% at 5 and 10 years, respectively. Local recurrence occurred in 23 patients at a median of 33 months (range, 6‐158 months), and metastasis occurred in 73 patients at a median of 20 months (range, 2‐166 months). In multivariate analysis, grade 3 tumors sized ≥5 cm were significantly associated with worse survival. Ten patients (5.2%) developed metastasis more than 5 years after surgery. Conclusion Tumor size and grade govern prognosis in surgically‐treated localized SS in long‐term settings. If adequately treated patients have not developed metastases for 5 years after surgery, the risk of subsequently developing metastases was lower than previously reported.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here